Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029
digiMedical Solutions, Inc., Microsoft Partner and Provider of Proprietary Digital Prescription Solution, Announces CEO Interview With WallStreet.net Today
CEO David Lee to Review Analyst Report and Anticipated $10 Million 2008 Revenue in Interview Today With WallStreet.net
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - February 25, 2008) - digiMedical Solutions, Inc. (PINKSHEETS : DGMS ) announced that Company CEO, David Lee, will interview with
WallStreet.net today, February 25. The interview will cover the company's
business plan to report an anticipated $10 million in profitable revenue in
2008. The Company currently has annualized revenue of approximately $6
million. digiMedical also anticipates an analyst report reviewing the
Company's current and future operations expected to be released later
today. The CEO interview will review the highlights of the analyst report.
digiMedical Solutions, a Microsoft Partner, with operations in Texas and
Florida, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy,
securely and in compliance with all DEA and HIPAA requirements. The suite
of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting and the Company owns and operates five pharmacies throughout
Texas and Florida.
digiMedical recently announced increasing the sales team in the Naples and
Fort Myers, Florida, markets to increase the Company's regional footprint
and support the Company's $10 million 2008 revenue goal.
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc. ™
digiMedical Solutions, Inc.™ (http://www.digimedical.com) is a pharmacy
and medical technology company focused on developing next-generation
digital medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions™' unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission for additional information and a
presentation of the risks and uncertainties that may affect the company's
business and results of operations.